3 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow Persistent Corneal Epithelial Defect: new trials by email Literature Review of Persistent Corneal Epithelial Defect trials Research Report on Persistent Corneal Epithelial Defect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of TP-06 for PCED TP-06, Vehicle of TP-06 - Persistent Corneal Epithelial Defect | Phase 2 | Recruiting | Tarsus Pharmaceuticals, Inc. | 32 | 2026-04-20 | 2026-10-21 |
| Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome, Vehicle Control - Persistent Corneal Epithelial Defect, Corneal Epithelial Disorders | Phase 2 | Recruiting | University of Illinois Chicago | 24 | 2025-08-01 | 2026-10-28 |
| A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED lufepirsen high dose, Vehicle, lufepirsen low dose - Persistent Corneal Epithelial Defect | Phase 2 | Recruiting | Glaukos Corporation | 84 | 2023-08-17 | 2025-07-24 |
Limbal Stem Cell Deficiency (1)
Corneal Diseases (1) · Eye Diseases (1)
Glaukos Corporation (1) · Tarsus Pharmaceuticals, Inc. (1) · University of Illinois Chicago (1)
United States (3) · Dominican Republic (1) · El Salvador (1) · Germany (1) · Italy (1) · Mexico (1) · Spain (1)
Ali R Djalilian, MD (1) · Luis G. Vargas, MD (1)
3UH3EY031809-04S1 (1)